Difference between revisions of "Part:BBa K5398610:Experience"
Jinmengliu (Talk | contribs) |
|||
Line 3: | Line 3: | ||
===Characterization=== | ===Characterization=== | ||
====Plasmid Construction==== | ====Plasmid Construction==== | ||
− | We considered cloning TyrVs into the pET-PC-SUMO vector to explore the potential for enhancing its expression level. We constructed the pET-PC-SUMO-TyrVs vector and transformed it into <i>E. coli</i>BL21(DE3). | + | We considered cloning TyrVs into the pET-PC-SUMO vector to explore the potential for enhancing its expression level. We constructed the pET-PC-SUMO-TyrVs vector and transformed it into <i>E.coli</i> BL21(DE3). |
<html lang="zh"> | <html lang="zh"> | ||
<head> | <head> | ||
Line 21: | Line 21: | ||
<body> | <body> | ||
<div class="module"> | <div class="module"> | ||
− | <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/sumo-tyrvs.webp" width=" | + | <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/sumo-tyrvs.webp" width="800" height="auto" alt="Protein purification"> |
<p><b>Fig. 2 | Plasmid pET-PC-SUMO-TyrVs construction results.</b></p> | <p><b>Fig. 2 | Plasmid pET-PC-SUMO-TyrVs construction results.</b></p> | ||
− | <p>a.Expression plasmids of TyrVs. b.PCR results of pET-PC-SUMO-TyrVs. Line 1: Marker | + | <p><b>a.</b>Expression plasmids of TyrVs. <b>b.</b>PCR results of pET-PC-SUMO-TyrVs. Line 1: Marker; Lines 2,3:Vector; Lines 4,5:Gene.</p> |
</div> | </div> | ||
</body> | </body> | ||
</html> | </html> | ||
+ | |||
====Protein expression==== | ====Protein expression==== | ||
− | + | A single colony from a freshly streaked plate of the cells was cultured in 5 mL of LB | |
− | from a freshly streaked plate of the cells was cultured in 5 mL of LB | + | |
medium with 25 μg/mL Ampicillin at 37℃ overnight. The secondary | medium with 25 μg/mL Ampicillin at 37℃ overnight. The secondary | ||
cultures were prepared with 1% inoculum in 50 mL of LB medium with 25 μg/mL Ampicillin. Cultures were | cultures were prepared with 1% inoculum in 50 mL of LB medium with 25 μg/mL Ampicillin. Cultures were | ||
Line 35: | Line 35: | ||
(OD<sub>600</sub>) reached 0.6–0.8. 1 mM IPTG was added to induce production of recombinant proteins and | (OD<sub>600</sub>) reached 0.6–0.8. 1 mM IPTG was added to induce production of recombinant proteins and | ||
cultures were further cultivated at 16℃ and 200 rpm for 20 h. The cells | cultures were further cultivated at 16℃ and 200 rpm for 20 h. The cells | ||
− | were collected by centrifugation at | + | were collected by centrifugation at 6000×<i>g</i> at 4℃ for 20 min.The recombinant cells were harvested by centrifugation and re-suspension in lysis buffer(10 mM imidazole, 50 mM Tris-HCl, 500 mM NaCl, pH 8.0)and lysed on ice by sonication.Sonicated samples were centrifuged at 12,000×<i>g</i> at 4 ℃ for 20 min to obtain insoluble and soluble fractions. After protein extraction, different proteins were separated by SDS-PAGE and stained with Coomassie Brilliant Blue. |
<html lang="zh"> | <html lang="zh"> | ||
<head> | <head> | ||
Line 54: | Line 54: | ||
<div class="module"> | <div class="module"> | ||
<img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/tyrvs-pre-expression.webp" width="400" height="auto" alt="Protein purification"> | <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/tyrvs-pre-expression.webp" width="400" height="auto" alt="Protein purification"> | ||
− | <p><b>Fig. 3 | Expression of recombinant TyrVs in <i>E. coli</i>BL21 (DE3) with pET-PC-SUMO-TyrVs.</b></p> | + | <p><b>Fig. 3 | Expression of recombinant TyrVs in <i>E.coli</i> BL21 (DE3) with pET-PC-SUMO-TyrVs.</b></p> |
− | <p>Lane 1: Marker | + | <p>Lane 1: Marker; lanes 2-4: whole-cell lysate, supernatant and pellet from induced cells with 0.5 mM IPTG respectively; lanes 5-7: whole-cell lysate, supernatant and pellet from induced cells respectively.</p> |
</div> | </div> | ||
</body> | </body> | ||
</html> | </html> | ||
+ | |||
====Western blotting==== | ====Western blotting==== | ||
Western bolotting revealed that after induction with IPTG, TyrVs was primarily expressed in its soluble form. | Western bolotting revealed that after induction with IPTG, TyrVs was primarily expressed in its soluble form. | ||
Line 79: | Line 80: | ||
<div class="module"> | <div class="module"> | ||
<img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/tyrvs-western.webp" width="300" height="auto" alt="Protein purification"> | <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/tyrvs-western.webp" width="300" height="auto" alt="Protein purification"> | ||
− | <p><b>Fig. 4 | Western blotting analysis recombinant TyrVs in <i>E. coli</i>BL21 (DE3) with pET-PC-SUMO-TyrVs.</b></p> | + | <p><b>Fig. 4 | Western blotting analysis recombinant TyrVs in <i>E.coli</i> BL21 (DE3) with pET-PC-SUMO-TyrVs.</b></p> |
− | <p> | + | <p> Lanes 1-3:whole-cell lysate,pellet and supernatant from induced cells with 0.5 mM IPTG respectively.</p> |
</div> | </div> | ||
</body> | </body> | ||
Line 102: | Line 103: | ||
<body> | <body> | ||
<div class="module"> | <div class="module"> | ||
− | <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/ | + | <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/sumo-tyrvs-mizuo-new.webp" width="400" height="auto" alt="Protein purification"> |
<p><b>Fig. 5 | SDS-PAGE analysis of protein fractions eluted from the Ni-NTA column.</b></p> | <p><b>Fig. 5 | SDS-PAGE analysis of protein fractions eluted from the Ni-NTA column.</b></p> | ||
− | <p>Lane 1: Marker | + | <p>Lane 1: Marker; Lane 2: Lysis Buffer; Lane 3: Supernatant; Lane 4: 20 mM Imidazole; Lane 5: 50 mM Imidazole; Lane 6: 150 mM Imidazole. </p> |
</div> | </div> | ||
</body> | </body> | ||
</html> | </html> | ||
+ | |||
====Enzyme activity test==== | ====Enzyme activity test==== | ||
− | We dialyzed the extracted SUMO-TyrVs for 24 | + | We dialyzed the extracted SUMO-TyrVs for 24 h, followed by diluting it 10,000-fold for enzymatic activity assays. In a 96 Well Cell Culture Plates, we prepared different concentrations of tyrosine and L-DOPA solution, added the diluted SUMO-TyrVs, and measured the change in OD<sub>475</sub> over the first 5 min using a microplate reader. |
<html lang="zh"> | <html lang="zh"> | ||
<head> | <head> | ||
Line 127: | Line 129: | ||
<body> | <body> | ||
<div class="module"> | <div class="module"> | ||
− | <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/tyrvs-96.webp" width=" | + | <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/tyrvs-96.webp" width="800" height="auto" alt="Protein purification"> |
<p><b>Fig. 6 | The 96 Well Cell Culture Plates of tyrosinase TyrVs.</b></p> | <p><b>Fig. 6 | The 96 Well Cell Culture Plates of tyrosinase TyrVs.</b></p> | ||
− | <p>a.The experiment of enzymatic reaction from tyrosine to dopaquinone. b.The experiment of enzymatic reaction from L-DOPA to dopaquinone. </p> | + | <p><b>a.</b>The experiment of enzymatic reaction from tyrosine to dopaquinone. <b>b.</b>The experiment of enzymatic reaction from L-DOPA to dopaquinone. </p> |
</div> | </div> | ||
</body> | </body> | ||
Line 151: | Line 153: | ||
<body> | <body> | ||
<div class="module"> | <div class="module"> | ||
− | <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/new-abcd.webp" width=" | + | <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/new-abcd.webp" width="800" height="auto" alt="Protein purification"> |
<p><b>Fig. 7 | The activity assay results of tyrosinase TyrVs</b></p> | <p><b>Fig. 7 | The activity assay results of tyrosinase TyrVs</b></p> | ||
− | <p>a-b.Michaelis-Menten plot and Lineweaver-Burk double reciprocal plot of enzymatic reaction from tyrosine to dopaquinone experiments. c-d.Michaelis-Menten plot and Lineweaver-Burk double reciprocal plot of enzymatic reaction from L-DOPA to dopaquinone experiments. </p> | + | <p><b>a-b.</b>Michaelis-Menten plot and Lineweaver-Burk double reciprocal plot of enzymatic reaction from tyrosine to dopaquinone experiments. <b>c-d.</b>Michaelis-Menten plot and Lineweaver-Burk double reciprocal plot of enzymatic reaction from L-DOPA to dopaquinone experiments. </p> |
</div> | </div> | ||
</body> | </body> | ||
</html> | </html> | ||
+ | |||
====Mathematical modeling Analysis==== | ====Mathematical modeling Analysis==== | ||
− | Tyrosinase exhibits dual catalytic properties, capable of catalyzing the conversion of tyrosine to L-DOPA and L-DOPA to dopaquinone. We analyzed through mathematical modeling to determine how to maximize the oxidation of tyrosine to L-DOPA. We selected multiple sets of parameters for fitting, and the goodness of fit | + | Tyrosinase exhibits dual catalytic properties, capable of catalyzing the conversion of tyrosine to L-DOPA and L-DOPA to dopaquinone. We analyzed through mathematical modeling to determine how to maximize the oxidation of tyrosine to L-DOPA. We selected multiple sets of parameters for fitting, and the goodness of fit R<sup>2</sup> was 0.9962, indicating a good fitting effect. We incorporated appropriate fitting parameters into the established model and determined that the optimal reaction time is approximately 130 sec, at which point the production of L-DOPA reaches its peak. To demonstrate that the reaction can proceed stably under conventional conditions, we introduced perturbations in each reaction channel.Under different disturbance conditions, the trend of dopamine quantity changes is similar, and the yield fluctuation is small, our reaction system has strong environmental adaptability and stability. |
<html lang="zh"> | <html lang="zh"> | ||
<head> | <head> | ||
Line 176: | Line 179: | ||
<body> | <body> | ||
<div class="module"> | <div class="module"> | ||
− | <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/model.webp" width=" | + | <img src="https://static.igem.wiki/teams/5398/tyrvs/tyrvs-new/model.webp" width="800" height="auto" alt="Protein purification"> |
<p><b>Fig. 7 | The activity assay results of tyrosinase TyrVs</b></p> | <p><b>Fig. 7 | The activity assay results of tyrosinase TyrVs</b></p> | ||
− | <p>a.Data fitting results. b.Changes in the concentrations of various substances in the reaction system. c.Changes in the concentration of substances in the system after adding disturbances.</p> | + | <p><b>a.</b>Data fitting results. <b>b.</b>Changes in the concentrations of various substances in the reaction system. <b>c.</b>Changes in the concentration of substances in the system after adding disturbances.</p> |
</div> | </div> | ||
</body> | </body> | ||
</html> | </html> |
Latest revision as of 08:37, 1 October 2024
Contents
Applications of BBa_K5398610
We use the plasmid pET-PC-SUMO-TyrVs to express the tyrosinase TyrVs(BBa_K5398600) which can oxidize tyrosine residues in TRn4-mfp5(BBa_K5398020) to L-DOPA,thereby endowing it with adhesion ability.
Characterization
Plasmid Construction
We considered cloning TyrVs into the pET-PC-SUMO vector to explore the potential for enhancing its expression level. We constructed the pET-PC-SUMO-TyrVs vector and transformed it into E.coli BL21(DE3).
Fig. 2 | Plasmid pET-PC-SUMO-TyrVs construction results.
a.Expression plasmids of TyrVs. b.PCR results of pET-PC-SUMO-TyrVs. Line 1: Marker; Lines 2,3:Vector; Lines 4,5:Gene.
Protein expression
A single colony from a freshly streaked plate of the cells was cultured in 5 mL of LB medium with 25 μg/mL Ampicillin at 37℃ overnight. The secondary cultures were prepared with 1% inoculum in 50 mL of LB medium with 25 μg/mL Ampicillin. Cultures were then incubated at 37℃ and 200 rpm until the optical density at 600 nm (OD600) reached 0.6–0.8. 1 mM IPTG was added to induce production of recombinant proteins and cultures were further cultivated at 16℃ and 200 rpm for 20 h. The cells were collected by centrifugation at 6000×g at 4℃ for 20 min.The recombinant cells were harvested by centrifugation and re-suspension in lysis buffer(10 mM imidazole, 50 mM Tris-HCl, 500 mM NaCl, pH 8.0)and lysed on ice by sonication.Sonicated samples were centrifuged at 12,000×g at 4 ℃ for 20 min to obtain insoluble and soluble fractions. After protein extraction, different proteins were separated by SDS-PAGE and stained with Coomassie Brilliant Blue.
Fig. 3 | Expression of recombinant TyrVs in E.coli BL21 (DE3) with pET-PC-SUMO-TyrVs.
Lane 1: Marker; lanes 2-4: whole-cell lysate, supernatant and pellet from induced cells with 0.5 mM IPTG respectively; lanes 5-7: whole-cell lysate, supernatant and pellet from induced cells respectively.
Western blotting
Western bolotting revealed that after induction with IPTG, TyrVs was primarily expressed in its soluble form.
Fig. 4 | Western blotting analysis recombinant TyrVs in E.coli BL21 (DE3) with pET-PC-SUMO-TyrVs.
Lanes 1-3:whole-cell lysate,pellet and supernatant from induced cells with 0.5 mM IPTG respectively.
Fig. 5 | SDS-PAGE analysis of protein fractions eluted from the Ni-NTA column.
Lane 1: Marker; Lane 2: Lysis Buffer; Lane 3: Supernatant; Lane 4: 20 mM Imidazole; Lane 5: 50 mM Imidazole; Lane 6: 150 mM Imidazole.
Enzyme activity test
We dialyzed the extracted SUMO-TyrVs for 24 h, followed by diluting it 10,000-fold for enzymatic activity assays. In a 96 Well Cell Culture Plates, we prepared different concentrations of tyrosine and L-DOPA solution, added the diluted SUMO-TyrVs, and measured the change in OD475 over the first 5 min using a microplate reader.
Fig. 6 | The 96 Well Cell Culture Plates of tyrosinase TyrVs.
a.The experiment of enzymatic reaction from tyrosine to dopaquinone. b.The experiment of enzymatic reaction from L-DOPA to dopaquinone.
Fig. 7 | The activity assay results of tyrosinase TyrVs
a-b.Michaelis-Menten plot and Lineweaver-Burk double reciprocal plot of enzymatic reaction from tyrosine to dopaquinone experiments. c-d.Michaelis-Menten plot and Lineweaver-Burk double reciprocal plot of enzymatic reaction from L-DOPA to dopaquinone experiments.
Mathematical modeling Analysis
Tyrosinase exhibits dual catalytic properties, capable of catalyzing the conversion of tyrosine to L-DOPA and L-DOPA to dopaquinone. We analyzed through mathematical modeling to determine how to maximize the oxidation of tyrosine to L-DOPA. We selected multiple sets of parameters for fitting, and the goodness of fit R2 was 0.9962, indicating a good fitting effect. We incorporated appropriate fitting parameters into the established model and determined that the optimal reaction time is approximately 130 sec, at which point the production of L-DOPA reaches its peak. To demonstrate that the reaction can proceed stably under conventional conditions, we introduced perturbations in each reaction channel.Under different disturbance conditions, the trend of dopamine quantity changes is similar, and the yield fluctuation is small, our reaction system has strong environmental adaptability and stability.
Fig. 7 | The activity assay results of tyrosinase TyrVs
a.Data fitting results. b.Changes in the concentrations of various substances in the reaction system. c.Changes in the concentration of substances in the system after adding disturbances.